Jyothy Labs (532926) Q3 25/26 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 25/26 earnings summary
15 Apr, 2026Executive summary
Q3 FY26 saw a favorable macro environment with easing inflation, GST rate cuts, and repo rate reductions supporting improved affordability and demand for daily essentials and home care products.
Q3 FY26 revenue rose 5.1% year-over-year to Rs 740 crores, with volume growth of 7.2%.
Rural markets remained strong due to good monsoons and stable farm income, while urban demand improved but remained value-driven and competitive, especially online.
Modern trade, e-commerce, and quick commerce channels delivered strong growth, and general trade recovered across all regions.
Un-audited financial results for the quarter and nine months ended December 31, 2025, were approved by the Board and reviewed by statutory auditors with no material misstatements identified.
Financial highlights
Q3 FY26 revenue from operations was INR 740 crores (₹73,961 lakhs), up 5.1% in value and 7.2% in volume year-on-year.
Gross margin for Q3 was 46.5%, down from 49.8% year-on-year due to MRP cuts, lower realizations, and elevated input costs.
EBITDA margin stood at 15%, down from 16.5% year-on-year; operating EBITDA was INR 111 crores (Rs 110.7 crores), and PAT was INR 81 crores (Rs 81.1 crores).
For the nine months ended December 2025, revenue was INR 2,227 crores (₹2,22,688 lakhs), gross margin 47.5% (vs. 50.4% prior year), EBITDA margin 15.9% (vs. 17.8%), and PAT INR 266 crores (vs. INR 294 crores prior year).
A&P spend was 7.7% of revenue in Q3 and 8% YTD.
Outlook and guidance
Management expects gross margins to remain subdued for at least the next couple of quarters due to ongoing input cost inflation and competitive intensity.
Focus on driving volume-led growth and premium product sales to achieve double-digit growth in the near term.
Continued investment in brands and innovation as long-term growth drivers.
No specific EBITDA margin guidance provided; management will reassess after observing market stabilization.
Cautiously optimistic about sustained consumption recovery, especially as macro conditions improve and cost discipline continues.
Latest events from Jyothy Labs
- Q1 FY25 revenue up 8% with margin expansion and growth across all core segments.532926
Q1 24/259 Jul 2026 - Q1 revenue rose 1.4% year-on-year, but margins fell; H2 recovery expected.532926
Q1 25/269 Jul 2026 - Flat revenue and profit, margin pressure, GST disruption, and strong cash flow position.532926
Q2 25/268 Jul 2026 - Q3 FY25 revenue up 4% YoY, margins steady, fabric care and dishwash led growth.532926
Q3 24/258 Jul 2026 - FY25 revenue and volume grew; margin recovery and new launches expected, outlook cautious.532926
Q4 24/2518 Jun 2026 - Gross margin and EBITDA improved, with e-commerce and new launches driving future growth.532926
Q2 24/2518 Jun 2026 - FY 2026 revenue rose 3.5% with strong volume growth, but margins declined amid cost pressures.532926
Q4 25/2611 May 2026